Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kumiko W. Shimotohno is active.

Publication


Featured researches published by Kumiko W. Shimotohno.


The Journal of Antibiotics | 2011

Molecular basis for the actions of Hsp90 inhibitors and cancer therapy.

Hiroshi Yamaki; Motowo Nakajima; Kumiko W. Shimotohno; Nobuo Tanaka

Heat-shock protein 90 (Hsp90) inhibitor downregulates c-Myc expression and upregulates the expression of tumor repressor proteins such as p53 and pRB, inhibiting the G1/S transition and causing G2/M arrest during cell cycle progression. The cycle progression is extensively controlled by the pRB/E2F signaling pathway. E2F is released from the pRB/E2F complex with the phosphorylation of pRB by cyclin–cyclin-dependent kinase (CDK) complexes. The released E2F promotes the transcription of target genes involved in cell cycle progression. The pRB/E2F signaling pathway is controlled by DNA methyltransferase-1 (Dnmt-1). The elevated expression of Dnmt-1 has been reported in carcinomas of the colon, lung and prostate. A defect of pRB expression in Rb−/− cancer cells is caused by the aberrant methylation of CpG in the Rb promoter. The Hsp90 inhibitor disrupts the Dnmt-1/Hsp90 association and upregulates pRB expression. In this review, the Hsp90 inhibitors that show promise for cancer therapy are summarized.


Journal of Virology | 2009

Genetic Analysis of Hepatitis C Virus with Defective Genome and Its Infectivity in Vitro

Kazuo Sugiyama; Kenji Suzuki; Takahide Nakazawa; Kenji Funami; Takayuki Hishiki; Kazuya Ogawa; Satoru Saito; Kumiko W. Shimotohno; Takeshi Suzuki; Yuko Shimizu; Reiri Tobita; Makoto Hijikata; Hiroshi Takaku; Kunitada Shimotohno

ABSTRACT Replication and infectivity of hepatitis C virus (HCV) with a defective genome is ambiguous. We molecularly cloned 38 HCV isolates with defective genomes from 18 patient sera. The structural regions were widely deleted, with the 5′ untranslated, core, and NS3-NS5B regions preserved. All of the deletions were in frame, indicating that they are translatable to the authentic terminus. Phylogenetic analyses showed self-replication of the defective genomes independent of full genomes. We generated a defective genome of chimeric HCV to mimic the defective isolate in the serum. By using this, we demonstrated for the first time that the defective genome, as it is circulating in the blood, can be encapsidated as an infectious particle by trans complementation of the structural proteins.


Neuroscience Letters | 2006

Continuous depolarization induces choline acetyltransferase activity in septal and hippocampal co-cultured embryonic rat neurons.

Takeshi Suzuki; Kumiko W. Shimotohno

We tested the influence of continuous high-K+ treatment on acetylcholine (ACh) release and choline acetyltransferase (ChAT) activity on septal cell culture, and septal and hippocampal cell co-culture obtained from rat embryos. Continuous 9 mM K+ treatment did not affect ACh release and ChAT activity in septal culture, but increased ACh release in co-culture without affecting ChAT activity. A slight increase in extracellular K+ concentration, therefore, induced neuronal excitation. Continuous 55 mM K+ treatment increased ACh release in septal culture. This effect was due to direct excitation of septal neurons. In co-culture, 55 mM K+ treatment increased both ACh release and ChAT activity. These results indicate that hippocampal neurons are indispensable for the depolarization-induced increase in ChAT activity in the early stage of developing septal cholinergic neurons.


Journal of the American Oil Chemists' Society | 1997

Antioxidant activity of Magnolol, honokiol, and related phenolic compounds

Masahiro Ogata; Midori Hoshi; Kumiko W. Shimotohno; Shiro Urano; Toyoshige Endo


Electrophoresis | 2002

Gerbils of a seizure-sensitive strain have a mitochondrial inner membrane protein with different isoelectric points from those of a seizure-resistant strain

Akira Omori; Sachiyo Ichinose; Satoko Kitajima; Kumiko W. Shimotohno; Yoshiya L. Murashima; Kunitada Shimotohno; Akiko Seto-Ohshima


The Journal of Antibiotics | 1993

ANTIBIOTIC AC6H, A NEW COMPONENT OF TETROCARCIN GROUP ANTIBIOTICS

Kumiko W. Shimotohno; Toyoshige Endo; Kazuo Furihata


Journal of Natural Medicines | 2006

Inhibitory effect of Yunnan traditional medicines on hepatitis C viral polymerase

Michiko Jo; Norio Nakamura; Nobuko Kakiuchi; Katsuko Komatsu; Ming-hua Qui; Kumiko W. Shimotohno; Kunitada Shimotohno; Masao Hattori


Biological & Pharmaceutical Bulletin | 1995

Inactivation of Blasticidin S by Bacillus cereus. V. Purification and Characterization of Blasticidin S-Deaminase Mediated by a Plasmid from Blasticidin S Resistant Bacillus cereus K55-S1

Kaori(Kobayashi) Nawa; Yuka Tamura; Kumiko Sato; Junichi Hattori; Kumiko W. Shimotohno; Toyoshige Endo


Bioscience, Biotechnology, and Biochemistry | 1997

Molecular cloning and nucleotide sequence of the arginase gene of Bacillus brevis TT02-8 and its expression in Escherichia coli

Kumiko W. Shimotohno; Ikuko Miwa; Toyoshige Endo


Biological & Pharmaceutical Bulletin | 2010

Inhibition of Septation in Bacillus subtilis by a Peptide Antibiotic, Edeine B1

Kumiko W. Shimotohno; Fujio Kawamura; Yousuke Natori; Hideaki Nanamiya; Hiromitsu Ogata; Toyoshige Endo; Takeshi Suzuki; Hiroshi Yamaki

Collaboration


Dive into the Kumiko W. Shimotohno's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kunitada Shimotohno

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Takeshi Suzuki

Tokyo University of Agriculture and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Midori Hoshi

Shibaura Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge